nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—CYP3A4—bone cancer	0.383	1	CbGaD
Cytarabine—ABCC10—Doxorubicin—bone cancer	0.147	0.393	CbGbCtD
Cytarabine—ABCC10—Methotrexate—bone cancer	0.142	0.38	CbGbCtD
Cytarabine—SLC22A2—Cisplatin—bone cancer	0.0765	0.205	CbGbCtD
Cytarabine—CYP3A4—Doxorubicin—bone cancer	0.00818	0.0219	CbGbCtD
Cytarabine—NT5E—periosteum—bone cancer	0.00815	0.241	CbGeAlD
Cytarabine—NT5E—cartilage tissue—bone cancer	0.00571	0.169	CbGeAlD
Cytarabine—NT5E—Nucleotide metabolism—NT5C3A—bone cancer	0.00301	0.0147	CbGpPWpGaD
Cytarabine—POLD1—Telomere C-strand (Lagging Strand) Synthesis—RFC1—bone cancer	0.00298	0.0145	CbGpPWpGaD
Cytarabine—POLE—Telomere C-strand (Lagging Strand) Synthesis—RFC1—bone cancer	0.00287	0.014	CbGpPWpGaD
Cytarabine—CDA—Nucleotide metabolism—NT5C3A—bone cancer	0.00276	0.0134	CbGpPWpGaD
Cytarabine—POLD1—Extension of Telomeres—RFC1—bone cancer	0.00247	0.012	CbGpPWpGaD
Cytarabine—POLE—Extension of Telomeres—RFC1—bone cancer	0.00239	0.0116	CbGpPWpGaD
Cytarabine—POLD1—DNA strand elongation—RFC1—bone cancer	0.00229	0.0111	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—DHFR—bone cancer	0.00223	0.0109	CbGpPWpGaD
Cytarabine—POLA1—Lagging Strand Synthesis—RFC1—bone cancer	0.0022	0.0107	CbGpPWpGaD
Cytarabine—POLD1—Global Genomic NER (GG-NER)—RFC1—bone cancer	0.00218	0.0106	CbGpPWpGaD
Cytarabine—POLB—DNA Repair—RFC1—bone cancer	0.00217	0.0106	CbGpPWpGaD
Cytarabine—POLD1—Nucleotide Metabolism—DHFR—bone cancer	0.00215	0.0105	CbGpPWpGaD
Cytarabine—POLE—Global Genomic NER (GG-NER)—RFC1—bone cancer	0.0021	0.0102	CbGpPWpGaD
Cytarabine—POLD1—Homologous recombination—BRCA2—bone cancer	0.00206	0.01	CbGpPWpGaD
Cytarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—RFC1—bone cancer	0.00205	0.00998	CbGpPWpGaD
Cytarabine—Glucosamine—MMP9—bone cancer	0.0019	0.796	CrCbGaD
Cytarabine—POLD1—DNA Replication—RFC1—bone cancer	0.00184	0.00896	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—RFC1—bone cancer	0.00178	0.00865	CbGpPWpGaD
Cytarabine—POLD1—Transcription-coupled NER (TC-NER)—RFC1—bone cancer	0.00174	0.00847	CbGpPWpGaD
Cytarabine—POLA1—Extension of Telomeres—RFC1—bone cancer	0.0017	0.00829	CbGpPWpGaD
Cytarabine—POLE—Transcription-coupled NER (TC-NER)—RFC1—bone cancer	0.00168	0.00818	CbGpPWpGaD
Cytarabine—POLA1—G1/S-Specific Transcription—DHFR—bone cancer	0.00162	0.00788	CbGpPWpGaD
Cytarabine—DCK—Nucleotide metabolism—NT5C3A—bone cancer	0.00161	0.00783	CbGpPWpGaD
Cytarabine—POLD1—Nucleotide Excision Repair—RFC1—bone cancer	0.0016	0.00779	CbGpPWpGaD
Cytarabine—POLA1—DNA strand elongation—RFC1—bone cancer	0.00157	0.00766	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—DHFR—bone cancer	0.00154	0.00752	CbGpPWpGaD
Cytarabine—POLE—Nucleotide Excision Repair—RFC1—bone cancer	0.00154	0.00752	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—IL3—bone cancer	0.00153	0.00745	CbGpPWpGaD
Cytarabine—POLB—bone marrow—bone cancer	0.00152	0.0448	CbGeAlD
Cytarabine—POLA1—Nucleotide Metabolism—DHFR—bone cancer	0.00148	0.00721	CbGpPWpGaD
Cytarabine—DCK—Doxorubicin—Epirubicin—bone cancer	0.00145	0.519	CbGdCrCtD
Cytarabine—NT5E—connective tissue—bone cancer	0.00142	0.042	CbGeAlD
Cytarabine—DCK—Epirubicin—Doxorubicin—bone cancer	0.00134	0.481	CbGdCrCtD
Cytarabine—POLA1—DNA Replication—RFC1—bone cancer	0.00127	0.00616	CbGpPWpGaD
Cytarabine—DCTD—tendon—bone cancer	0.00126	0.0373	CbGeAlD
Cytarabine—DCTD—bone marrow—bone cancer	0.00122	0.0361	CbGeAlD
Cytarabine—DCTD—spinal cord—bone cancer	0.00122	0.036	CbGeAlD
Cytarabine—CDA—tendon—bone cancer	0.00115	0.0339	CbGeAlD
Cytarabine—POLD1—Telomere Maintenance—RFC1—bone cancer	0.00112	0.00546	CbGpPWpGaD
Cytarabine—CDA—bone marrow—bone cancer	0.00111	0.0328	CbGeAlD
Cytarabine—POLE—Telomere Maintenance—RFC1—bone cancer	0.00108	0.00527	CbGpPWpGaD
Cytarabine—NT5E—tendon—bone cancer	0.000976	0.0288	CbGeAlD
Cytarabine—POLA1—Inhibition of replication initiation of damaged DNA by RB1/E2F1—RB1—bone cancer	0.000976	0.00475	CbGpPWpGaD
Cytarabine—POLE—tendon—bone cancer	0.000956	0.0283	CbGeAlD
Cytarabine—POLB—DNA Repair—BRCA2—bone cancer	0.000954	0.00465	CbGpPWpGaD
Cytarabine—POLA1—E2F mediated regulation of DNA replication—DHFR—bone cancer	0.000951	0.00463	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—RFC1—bone cancer	0.000949	0.00462	CbGpPWpGaD
Cytarabine—NT5E—bone marrow—bone cancer	0.000946	0.0279	CbGeAlD
Cytarabine—NT5E—spinal cord—bone cancer	0.000942	0.0278	CbGeAlD
Cytarabine—POLD1—Chromosome Maintenance—RFC1—bone cancer	0.000933	0.00455	CbGpPWpGaD
Cytarabine—POLE—bone marrow—bone cancer	0.000926	0.0274	CbGeAlD
Cytarabine—POLE—Synthesis of DNA—RFC1—bone cancer	0.000916	0.00446	CbGpPWpGaD
Cytarabine—POLE—Chromosome Maintenance—RFC1—bone cancer	0.000901	0.00439	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—KIT—bone cancer	0.000893	0.00435	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—RFC1—bone cancer	0.00089	0.00434	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—RFC1—bone cancer	0.00086	0.00419	CbGpPWpGaD
Cytarabine—POLD1—DNA Repair—RFC1—bone cancer	0.000833	0.00406	CbGpPWpGaD
Cytarabine—POLA1—tendon—bone cancer	0.000824	0.0243	CbGeAlD
Cytarabine—POLE—DNA Repair—RFC1—bone cancer	0.000804	0.00392	CbGpPWpGaD
Cytarabine—POLA1—bone marrow—bone cancer	0.000798	0.0236	CbGeAlD
Cytarabine—POLD1—S Phase—RFC1—bone cancer	0.000778	0.00379	CbGpPWpGaD
Cytarabine—SLC29A1—connective tissue—bone cancer	0.000774	0.0229	CbGeAlD
Cytarabine—POLA1—Telomere Maintenance—RFC1—bone cancer	0.000771	0.00376	CbGpPWpGaD
Cytarabine—POLE—S Phase—RFC1—bone cancer	0.000752	0.00366	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—RFC1—bone cancer	0.000653	0.00318	CbGpPWpGaD
Cytarabine—POLA1—Chromosome Maintenance—RFC1—bone cancer	0.000642	0.00313	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000615	0.00299	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—RFC1—bone cancer	0.000612	0.00298	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000598	0.00292	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—NDUFA12—bone cancer	0.000575	0.0028	CbGpPWpGaD
Cytarabine—POLA1—S Phase—RFC1—bone cancer	0.000536	0.00261	CbGpPWpGaD
Cytarabine—SLC29A1—tendon—bone cancer	0.000532	0.0157	CbGeAlD
Cytarabine—SLC29A1—bone marrow—bone cancer	0.000515	0.0152	CbGeAlD
Cytarabine—POLE—G1/S Transition—DHFR—bone cancer	0.000513	0.0025	CbGpPWpGaD
Cytarabine—DCK—tendon—bone cancer	0.000508	0.015	CbGeAlD
Cytarabine—POLA1—E2F transcription factor network—DHFR—bone cancer	0.000504	0.00246	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—TP53—bone cancer	0.000498	0.00243	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—ZW10—bone cancer	0.000498	0.00243	CbGpPWpGaD
Cytarabine—DCK—bone marrow—bone cancer	0.000492	0.0145	CbGeAlD
Cytarabine—DCK—spinal cord—bone cancer	0.00049	0.0145	CbGeAlD
Cytarabine—Zalcitabine—CYP3A4—bone cancer	0.000487	0.204	CrCbGaD
Cytarabine—ABCC10—tendon—bone cancer	0.000484	0.0143	CbGeAlD
Cytarabine—DCTD—Metabolism—NT5C3A—bone cancer	0.000477	0.00232	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000474	0.00231	CbGpPWpGaD
Cytarabine—ABCC10—bone marrow—bone cancer	0.000469	0.0139	CbGeAlD
Cytarabine—ABCC10—spinal cord—bone cancer	0.000467	0.0138	CbGeAlD
Cytarabine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000454	0.00221	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000438	0.00213	CbGpPWpGaD
Cytarabine—POLA1—E2F mediated regulation of DNA replication—RB1—bone cancer	0.000434	0.00212	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000433	0.00211	CbGpPWpGaD
Cytarabine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000427	0.00208	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—CDK4—bone cancer	0.000393	0.00192	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—ZW10—bone cancer	0.000386	0.00188	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—ZW10—bone cancer	0.000372	0.00181	CbGpPWpGaD
Cytarabine—POLD1—DNA Repair—BRCA2—bone cancer	0.000366	0.00178	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—DHFR—bone cancer	0.000366	0.00178	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—ZW10—bone cancer	0.000355	0.00173	CbGpPWpGaD
Cytarabine—POLE—DNA Repair—BRCA2—bone cancer	0.000353	0.00172	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TP53—bone cancer	0.000345	0.00168	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—ZW10—bone cancer	0.000345	0.00168	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—RB1—bone cancer	0.000342	0.00167	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000338	0.00165	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—ZW10—bone cancer	0.000333	0.00162	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—NDUFA12—bone cancer	0.00033	0.00161	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000323	0.00157	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000314	0.00153	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000308	0.0015	CbGpPWpGaD
Cytarabine—CDA—Metabolism—NDUFA12—bone cancer	0.000302	0.00147	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000292	0.00142	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—MDM2—bone cancer	0.000292	0.00142	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000292	0.00142	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000282	0.00137	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000281	0.00137	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000281	0.00137	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—PLAU—bone cancer	0.00028	0.00136	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—NT5C3A—bone cancer	0.000274	0.00133	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000273	0.00133	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—RB1—bone cancer	0.000269	0.00131	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000268	0.0013	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—ZW10—bone cancer	0.000265	0.00129	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—RFC1—bone cancer	0.000265	0.00129	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TUBB4B—bone cancer	0.000261	0.00127	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—RB1—bone cancer	0.00026	0.00126	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—RFC1—bone cancer	0.000256	0.00125	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CDK4—bone cancer	0.000253	0.00123	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TUBB4B—bone cancer	0.000252	0.00123	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—RB1—bone cancer	0.000252	0.00123	CbGpPWpGaD
Cytarabine—CDA—Metabolism—NT5C3A—bone cancer	0.00025	0.00122	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000245	0.0012	CbGpPWpGaD
Cytarabine—POLE—S Phase—CDK4—bone cancer	0.000245	0.00119	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—RB1—bone cancer	0.000243	0.00119	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000239	0.00117	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000239	0.00116	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—ZW10—bone cancer	0.000237	0.00116	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—RFC1—bone cancer	0.000237	0.00115	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—RB1—bone cancer	0.000234	0.00114	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000233	0.00114	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000231	0.00113	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—RB1—bone cancer	0.00023	0.00112	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.00023	0.00112	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—RFC1—bone cancer	0.000229	0.00111	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000227	0.00111	CbGpPWpGaD
Cytarabine—POLD1—S Phase—RB1—bone cancer	0.00022	0.00107	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000217	0.00106	CbGpPWpGaD
Cytarabine—POLE—S Phase—RB1—bone cancer	0.000213	0.00104	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ENO2—bone cancer	0.000209	0.00102	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000201	0.00098	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.0002	0.000975	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000198	0.000964	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—RB1—bone cancer	0.000198	0.000962	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000195	0.000952	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000195	0.000951	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—DHFR—bone cancer	0.000194	0.000943	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NDUFA12—bone cancer	0.000187	0.000913	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—RB1—bone cancer	0.000185	0.000901	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RFC1—bone cancer	0.000182	0.000888	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GNA11—bone cancer	0.000181	0.000882	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TUBB4B—bone cancer	0.00018	0.000876	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NDUFA12—bone cancer	0.000176	0.000858	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CDK4—bone cancer	0.000174	0.00085	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—RB1—bone cancer	0.000173	0.000845	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000171	0.000831	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—bone cancer	0.000167	0.000815	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—RB1—bone cancer	0.000167	0.000814	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000165	0.000806	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—DHFR—bone cancer	0.000164	0.0008	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CYP3A4—bone cancer	0.000164	0.000799	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RFC1—bone cancer	0.000163	0.000794	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000162	0.000789	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—DHFR—bone cancer	0.000159	0.000773	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NT5C3A—bone cancer	0.000155	0.000756	CbGpPWpGaD
Cytarabine—POLA1—S Phase—RB1—bone cancer	0.000152	0.000739	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—DHFR—bone cancer	0.000147	0.000715	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NT5C3A—bone cancer	0.000146	0.000711	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—DHFR—bone cancer	0.000142	0.000691	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—RB1—bone cancer	0.000141	0.000686	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GSTP1—bone cancer	0.00014	0.000684	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000137	0.000669	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000134	0.000651	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CHEK2—bone cancer	0.000123	0.000598	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000123	0.000598	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ENO2—bone cancer	0.00012	0.000584	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CHEK2—bone cancer	0.000119	0.000578	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—DHFR—bone cancer	0.000113	0.000551	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—DHFR—bone cancer	0.000111	0.000542	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ENO2—bone cancer	0.00011	0.000534	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—BRCA2—bone cancer	0.000104	0.000507	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GNA11—bone cancer	0.000104	0.000506	CbGpPWpGaD
Cytarabine—CDA—Metabolism—DHFR—bone cancer	0.000102	0.000496	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—DHFR—bone cancer	0.000101	0.000492	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—BRCA2—bone cancer	0.0001	0.000489	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—bone cancer	9.79e-05	0.000477	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—RB1—bone cancer	9.69e-05	0.000472	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GNA11—bone cancer	9.51e-05	0.000463	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CYP3A4—bone cancer	9.42e-05	0.000459	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	9.09e-05	0.000443	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.93e-05	0.000435	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	8.77e-05	0.000427	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDK4—bone cancer	8.63e-05	0.00042	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP3A4—bone cancer	8.62e-05	0.00042	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CHEK2—bone cancer	8.45e-05	0.000412	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDK4—bone cancer	8.33e-05	0.000406	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.32e-05	0.000405	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GSTP1—bone cancer	8.06e-05	0.000393	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	7.9e-05	0.000385	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDK4—bone cancer	7.71e-05	0.000376	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.7e-05	0.000375	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—RB1—bone cancer	7.5e-05	0.000365	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDK4—bone cancer	7.45e-05	0.000363	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GSTP1—bone cancer	7.37e-05	0.000359	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—bone cancer	7.27e-05	0.000354	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—RB1—bone cancer	7.25e-05	0.000353	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.18e-05	0.00035	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BRCA2—bone cancer	7.16e-05	0.000349	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NDUFA12—bone cancer	6.98e-05	0.00034	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—RB1—bone cancer	6.9e-05	0.000336	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ENO2—bone cancer	6.8e-05	0.000331	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—RB1—bone cancer	6.71e-05	0.000327	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NDUFA12—bone cancer	6.5e-05	0.000317	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—RB1—bone cancer	6.48e-05	0.000316	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ENO2—bone cancer	6.39e-05	0.000312	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—DHFR—bone cancer	6.31e-05	0.000307	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	6.21e-05	0.000303	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDK4—bone cancer	5.94e-05	0.000289	CbGpPWpGaD
Cytarabine—DCK—Metabolism—DHFR—bone cancer	5.93e-05	0.000289	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GNA11—bone cancer	5.9e-05	0.000287	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NT5C3A—bone cancer	5.78e-05	0.000282	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MDM2—bone cancer	5.72e-05	0.000279	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	5.66e-05	0.000276	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GNA11—bone cancer	5.54e-05	0.00027	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MDM2—bone cancer	5.52e-05	0.000269	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NT5C3A—bone cancer	5.39e-05	0.000263	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP3A4—bone cancer	5.35e-05	0.00026	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDK4—bone cancer	5.31e-05	0.000259	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—BRAF—bone cancer	5.28e-05	0.000257	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	5.22e-05	0.000254	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.17e-05	0.000252	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RB1—bone cancer	5.16e-05	0.000252	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP3A4—bone cancer	5.03e-05	0.000245	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	4.74e-05	0.000231	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RB1—bone cancer	4.62e-05	0.000225	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GSTP1—bone cancer	4.57e-05	0.000223	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MDM2—bone cancer	4.42e-05	0.000215	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—BRAF—bone cancer	4.34e-05	0.000211	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GSTP1—bone cancer	4.3e-05	0.000209	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—bone cancer	4.18e-05	0.000203	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—BRAF—bone cancer	4.04e-05	0.000197	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MDM2—bone cancer	3.94e-05	0.000192	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—bone cancer	3.82e-05	0.000186	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MDM2—bone cancer	3.63e-05	0.000177	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MDM2—bone cancer	3.39e-05	0.000165	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.35e-05	0.000163	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.31e-05	0.000161	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—bone cancer	3.28e-05	0.00016	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—bone cancer	3.17e-05	0.000154	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ENO2—bone cancer	2.53e-05	0.000123	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—bone cancer	2.37e-05	0.000115	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ENO2—bone cancer	2.36e-05	0.000115	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—DHFR—bone cancer	2.35e-05	0.000114	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NDUFA12—bone cancer	2.35e-05	0.000114	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—bone cancer	2.26e-05	0.00011	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—bone cancer	2.23e-05	0.000108	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GNA11—bone cancer	2.2e-05	0.000107	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—DHFR—bone cancer	2.19e-05	0.000107	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GNA11—bone cancer	2.05e-05	9.97e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP3A4—bone cancer	1.99e-05	9.7e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NT5C3A—bone cancer	1.95e-05	9.48e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP3A4—bone cancer	1.86e-05	9.04e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GSTP1—bone cancer	1.7e-05	8.29e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GSTP1—bone cancer	1.59e-05	7.73e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—bone cancer	8.82e-06	4.3e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ENO2—bone cancer	8.52e-06	4.15e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—bone cancer	8.22e-06	4.01e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—DHFR—bone cancer	7.91e-06	3.85e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GNA11—bone cancer	7.39e-06	3.6e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GSTP1—bone cancer	5.73e-06	2.79e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—bone cancer	2.97e-06	1.45e-05	CbGpPWpGaD
